| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.9M | — | +45.2% |
| Cost of Revenue | $9.9M | — | +36.4% |
| Gross Profit | $3.0M | — | +83.8% |
| R&D Expense | $1.2M | — | +19.8% |
| SG&A Expense | $3.5M | — | +30.4% |
| Operating Income | -$1.7M | — | +17.2% |
| Pre-tax Income | -$2.9M | — | +55.4% |
| Net Income | -$2.9M | +27.3% | +55.4% |
| EPS (Basic) | -$0.19 | — | +58.7% |
| EPS (Diluted) | -$0.19 | — | +58.7% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.4M | — | — |
| Accounts Receivable | $1.2M | — | — |
| Inventory | $7.9M | — | — |
| Current Assets | $12.9M | — | — |
| Total Assets | $20.4M | — | — |
| Current Liabilities | $12.9M | — | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.3M | — | — |
| Capital Expenditures | $332K | — | — |
| Investing Cash Flow | -$354K | — | — |
| Financing Cash Flow | $1.5M | — | — |
| Free Cash Flow | -$1.6M | — | — |
| Total Liabilities |
| $83.8M |
| — |
| — |
| Stockholders' Equity | -$63.4M | -3.5% | -15.1% |